2 Wide Moats in Health Care
Distributors Henry Schein and Patterson should be able to maintain their competitive advantages over the long run and deserve a spot on investors' watchlists.
Distributors Henry Schein and Patterson should be able to maintain their competitive advantages over the long run and deserve a spot on investors' watchlists.
Michael Waterhouse: Henry Schein (HSIC) and Patterson (PDCO) are two unique health-care companies that we rate wide moat, and we think they have wide moats for a few basic reasons. First, they have a very broad distribution scale that helps give them a low-cost edge amongst competitors.
Second, they also distribute to a very fragmented base of customers and suppliers in the U.S. We're talking roughly over 180,000 dentists and 60,000 veterinarians, and that helps keep pricing power stable.
And then lastly, a lot of these customers are sole practitioners, so they are dependent on these companies for a lot of back-office functions, such as software, repairing equipment, networking their systems, and so on. So, that helps keep customers a little bit more loyal to these businesses.
And we think they'll be able to sustain roughly 70% market share in the dental market and about 60% market share combined in the veterinary market. So, we continue to like the moats for these companies over the long term. We currently think that they're both roughly fairly valued, but we think investors should keep them on their watchlist for a future point of entry.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.